Patients with government insurance (Medicare, Medicaid) or no insurance often find themselves ineligible, and those without a participating pharmacy nearby face additional barriers
External resources For anyone serious about managing their GLP-1 medication safely and effectively, SeekPeptides offers the most comprehensive resource available, with evidence-based storage guides, stability databases, handling protocols, and a community of thousands who have navigated these exact situations
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Remember, this is essential, as medication errors can greatly influence your health results
If future studies continue to confirm its benefits, retatrutide could emerge as one of the most powerful treatment options yet for people living with type 2 diabetes and obesity
In April 2025, President Donald Trumps administration declined to expand Medicare Part D and Medicare Advantage plans to cover GLP-1s for weight-loss.